Study Finds Serotonin Plays a Role in Development of Mammary Glands
The development of mammary glands is controlled primarily by endocrine hormones. A study led by Nelson Horseman, PhD, professor and interim chair of the Department of Molecular and Cellular Physiology at the
, shows that serotonin (a brain neurotransmitter) also plays a role in mammary gland development. Findings from this study appear in the Feb. 10 issue of
Developmental Cell
in an article titled "Serotonin Regulates Mammary Gland Development via an Autocrine Paracrine Loop."
"It was a complete surprise when we found that serotonin, a chemical best known for its involvement in mood regulation, plays an important role in controlling the secretion of milk in the mammary glands," said Dr. Horseman.
Serotonin, along with other regulatory hormones such as dopamine and adrenaline, is classified as a biogenic monoamine. Until now, this molecule has not been associated with the development of mammary glands. Dr. Horseman's group found that mammary glands stimulated by prolactin express genes necessary for the biosynthesis of serotonin.
Findings from this study may suggest that drugs that alter serotonin synthesis or activity could have effects on milk production, milk quality, or breast cancer.
Co-authors from UC include: Manabu Matsuda, PhD, former postdoctoral fellow; Tatsuhiko Imaoka, PhD, former graduate student; Archie J. Vomachka, PhD, visiting professor from Arcadia University in Pennsylvania; Gary A. Gudelsky, PhD, professor in the UC College of Pharmacy; Zhaoyuan Hou, PhD, former graduate student; Meenakshi Mistry, research associate in the Department of Molecular and Cellular Physiology; Jason P. Bailey, graduate student in the Department of Molecular and Cellular Physiology; and Kathryn M. Nieport, research assistant in the Department of Molecular and Cellular Physiology.
View the entire article online at
Tags
Related Stories
UC joins bipolar research network
March 18, 2025
The Cincinnati Business Courier and Spectrum News highlighted the University of Cincinnati receiving a $2.3 million grant to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.
Tenecteplase no longer 'off label' for acute ischemic stroke
March 17, 2025
The University of Cincinnati's Yasmin Aziz was featured in a MedCentral article discussing the recent FDA approval of the drug tenecteplase for treatment of acute ischemic stroke.
UC joins novel bipolar research and clinical care network
March 12, 2025
The University of Cincinnati is one of four new national institutions to receive $2.3 million each to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.